Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy

Dynamic regulation of gene expression is fundamental for cellular adaptation to exogenous stressors. P-TEFb-mediated pause-release of RNA polymerase II (Pol II) is a conserved regulatory mechanism for synchronous transcriptional induction in response to heat shock, but this pro-survival role has not...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 15; no. 1; pp. 4616 - 21
Main Authors Walker, Faye M, Sobral, Lays Martin, Danis, Etienne, Sanford, Bridget, Donthula, Sahiti, Balakrishnan, Ilango, Wang, Dong, Pierce, Angela, Karam, Sana D, Kargar, Soudabeh, Serkova, Natalie J, Foreman, Nicholas K, Venkataraman, Sujatha, Dowell, Robin, Vibhakar, Rajeev, Dahl, Nathan A
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 30.05.2024
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dynamic regulation of gene expression is fundamental for cellular adaptation to exogenous stressors. P-TEFb-mediated pause-release of RNA polymerase II (Pol II) is a conserved regulatory mechanism for synchronous transcriptional induction in response to heat shock, but this pro-survival role has not been examined in the applied context of cancer therapy. Using model systems of pediatric high-grade glioma, we show that rapid genome-wide reorganization of active chromatin facilitates P-TEFb-mediated nascent transcriptional induction within hours of exposure to therapeutic ionizing radiation. Concurrent inhibition of P-TEFb disrupts this chromatin reorganization and blunts transcriptional induction, abrogating key adaptive programs such as DNA damage repair and cell cycle regulation. This combination demonstrates a potent, synergistic therapeutic potential agnostic of glioma subtype, leading to a marked induction of tumor cell apoptosis and prolongation of xenograft survival. These studies reveal a central role for P-TEFb underpinning the early adaptive response to radiotherapy, opening avenues for combinatorial treatment in these lethal malignancies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-024-48214-3